20 The decision to offer aromatase inhibitors to higher risk patients is largely based on the results of published RCTs 21 27 and systematic reviews 28 31 of women with ER early breast cancer suggesting a modest benefit for patients taking aromatase inhibitors over those taking TAM acheter levitra online Brody JbRctlPAaNvSmxZTB 6 16 2022